Skip to primary navigation
Skip to main content
Skip to footer
Neurotech International
ASX:NTI
Home
Corporate
Board and Management
Corporate Directory
Corporate Governance
Corporate Videos
Development Programs
Biopharmaceutical Trials
Group Strategy and Target Markets
NTI164
Clinical Trials
Pathways to Commercialisation
Investors
Investor Dashboard
ASX Announcements
Investor Conference Calls
Company Reports
Presentations
Research
News & Media
Fact Sheets
Analyst Reports
Right to Receive Documents
Contact
Gerald Quigley, short discussion on 4RO Rockhampton regarding Autism
2 August 2022
News & Media
4RO
Download prospectus
CLOSE